|
Enfusion, Inc. (ENFN) DCF -Bewertung
US | Technology | Software - Application | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Enfusion, Inc. (ENFN) Bundle
Entdecken Sie die finanzielle Zukunft von Enfusion, Inc. (ENFN) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Margen und Kosten ein, um den inneren Wert von Enfusion, Inc. (ENFN) zu berechnen und Ihren Investitionsansatz zu verfeinern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59.0 | 79.6 | 111.7 | 150.3 | 174.5 | 229.5 | 301.7 | 396.6 | 521.4 | 685.4 |
| Revenue Growth, % | 0 | 34.79 | 40.39 | 34.6 | 16.09 | 31.47 | 31.47 | 31.47 | 31.47 | 31.47 |
| EBITDA | 15.0 | 8.4 | -271.9 | -5.6 | 21.9 | -25.3 | -33.3 | -43.8 | -57.6 | -75.7 |
| EBITDA, % | 25.45 | 10.51 | -243.43 | -3.74 | 12.57 | -11.04 | -11.04 | -11.04 | -11.04 | -11.04 |
| Depreciation | 1.2 | 2.3 | 4.0 | 6.6 | 10.0 | 8.5 | 11.2 | 14.7 | 19.3 | 25.4 |
| Depreciation, % | 1.96 | 2.88 | 3.56 | 4.39 | 5.72 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 |
| EBIT | 13.9 | 6.1 | -275.9 | -12.2 | 11.9 | -32.2 | -42.3 | -55.6 | -73.2 | -96.2 |
| EBIT, % | 23.49 | 7.63 | -246.99 | -8.13 | 6.85 | -14.03 | -14.03 | -14.03 | -14.03 | -14.03 |
| Total Cash | 5.9 | 13.9 | 64.4 | 62.5 | 35.6 | 67.5 | 88.8 | 116.7 | 153.4 | 201.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 9.0 | 12.2 | 18.2 | 25.9 | 28.1 | 36.8 | 48.3 | 63.5 | 83.5 | 109.8 |
| Account Receivables, % | 15.2 | 15.31 | 16.31 | 17.2 | 16.08 | 16.02 | 16.02 | 16.02 | 16.02 | 16.02 |
| Inventories | .0 | .0 | .0 | 6.1 | .0 | 1.9 | 2.4 | 3.2 | 4.2 | 5.6 |
| Inventories, % | 0.00000169414 | 0 | 0.000000895 | 4.06 | 0 | 0.81211 | 0.81211 | 0.81211 | 0.81211 | 0.81211 |
| Accounts Payable | .4 | .5 | 2.5 | 1.7 | 2.2 | 2.8 | 3.6 | 4.8 | 6.3 | 8.2 |
| Accounts Payable, % | 0.7505 | 0.60831 | 2.26 | 1.12 | 1.27 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Capital Expenditure | -4.4 | -5.1 | -8.0 | -7.9 | -9.7 | -14.6 | -19.2 | -25.3 | -33.2 | -43.7 |
| Capital Expenditure, % | -7.5 | -6.37 | -7.17 | -5.28 | -5.54 | -6.37 | -6.37 | -6.37 | -6.37 | -6.37 |
| Tax Rate, % | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 | 47.54 |
| EBITAT | 13.4 | 5.5 | -276.5 | -13.3 | 6.3 | -28.3 | -37.2 | -48.9 | -64.3 | -84.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1.5 | -.5 | -284.5 | -29.2 | 11.0 | -44.4 | -56.5 | -74.3 | -97.7 | -128.4 |
| WACC, % | 8.54 | 8.53 | 8.54 | 8.54 | 8.52 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -302.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -131 | |||||||||
| Terminal Value | -2,005 | |||||||||
| Present Terminal Value | -1,331 | |||||||||
| Enterprise Value | -1,634 | |||||||||
| Net Debt | -20 | |||||||||
| Equity Value | -1,614 | |||||||||
| Diluted Shares Outstanding, MM | 129 | |||||||||
| Equity Value Per Share | -12.47 |
What You Will Get
- Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Enfusion, Inc.’s financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that caters to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Financial Metrics: Adjust essential inputs such as revenue growth, operating margins, and capital expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
- High-Precision Accuracy: Leverages Enfusion's real-world financial data for reliable valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Avoid the hassle of creating intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Enfusion, Inc. (ENFN).
- Step 2: Review Enfusion's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose the Enfusion Calculator?
- User-Friendly Interface: Perfect for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Adjustments: Monitor immediate changes to Enfusion’s valuation as you tweak inputs.
- Preloaded Data: Comes with Enfusion’s actual financial metrics for swift evaluations.
- Relied Upon by Experts: Preferred by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Gain a precise understanding of Enfusion, Inc.'s (ENFN) intrinsic value before making investment choices.
- CFOs: Utilize a robust DCF model for comprehensive financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Discover financial modeling techniques employed by leading firms.
- Educators: Employ it as a resource for teaching valuation methods and practices.
What the Template Contains
- Pre-Filled Data: Includes Enfusion, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Enfusion, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.